426 related articles for article (PubMed ID: 36923933)
1. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
2. Curcumin in human osteosarcoma: From analogs to carriers.
Lu KH; Lu PW; Lin CW; Yang SF
Drug Discov Today; 2023 Feb; 28(2):103437. PubMed ID: 36372327
[TBL] [Abstract][Full Text] [Related]
3. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
[TBL] [Abstract][Full Text] [Related]
4. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of MG-63 osteosarcoma cell proliferation induced by curcumin-loaded self-assembled arginine-rich-RGD nanospheres.
Chang R; Sun L; Webster TJ
Int J Nanomedicine; 2015; 10():3351-65. PubMed ID: 26005346
[TBL] [Abstract][Full Text] [Related]
6. Liposome-Encapsulated Curcumin-Loaded 3D Printed Scaffold for Bone Tissue Engineering.
Sarkar N; Bose S
ACS Appl Mater Interfaces; 2019 May; 11(19):17184-17192. PubMed ID: 30924639
[TBL] [Abstract][Full Text] [Related]
7. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
Gota VS; Maru GB; Soni TG; Gandhi TR; Kochar N; Agarwal MG
J Agric Food Chem; 2010 Feb; 58(4):2095-9. PubMed ID: 20092313
[TBL] [Abstract][Full Text] [Related]
8. Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway.
Aziz MNM; Hussin Y; Che Rahim NF; Nordin N; Mohamad NE; Yeap SK; Yong CY; Masarudin MJ; Cheah YK; Abu N; Akhtar MN; Alitheen NB
Molecules; 2018 Jan; 23(1):. PubMed ID: 29303982
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
Yang Z; Liu J; Lu Y
Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
[TBL] [Abstract][Full Text] [Related]
10. Properties, Extraction Methods, and Delivery Systems for Curcumin as a Natural Source of Beneficial Health Effects.
Zielińska A; Alves H; Marques V; Durazzo A; Lucarini M; Alves TF; Morsink M; Willemen N; Eder P; Chaud MV; Severino P; Santini A; Souto EB
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32635279
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-Microsphere/IR820 Hybrid Bifunctional Hydrogels for In Situ Osteosarcoma Chemo-
Tan B; Wu Y; Wu Y; Shi K; Han R; Li Y; Qian Z; Liao J
ACS Appl Mater Interfaces; 2021 Jul; 13(27):31542-31553. PubMed ID: 34191477
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity Enhancement in Osteosarcoma with Multifunctional I-131 Radiotherapeutic Nanoparticles: In Vitro Three-Dimensional Spheroid Model and Release Kinetics Modeling.
Marshall SK; Taweesap M; Saelim B; Pachana V; Benlateh N; Sangangam S; Bumrungsin A; Kholo-Asae H; Wongtechanon I
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338373
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic effects of curcumin on human osteosarcoma U2OS cells.
Jin S; Xu HG; Shen JN; Chen XW; Wang H; Zhou JG
Orthop Surg; 2009 May; 1(2):144-52. PubMed ID: 22009832
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Promotes Osteosarcoma Cell Death by Activating miR-125a/ERRα Signal Pathway.
Chen P; Wang H; Yang F; Chen H; He W; Wang J
J Cell Biochem; 2017 Jan; 118(1):74-81. PubMed ID: 27231954
[TBL] [Abstract][Full Text] [Related]
16. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
Lee DS; Lee MK; Kim JH
Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
[TBL] [Abstract][Full Text] [Related]
17. Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts.
Chang R; Sun L; Webster TJ
Int J Nanomedicine; 2014; 9():461-5. PubMed ID: 24453488
[TBL] [Abstract][Full Text] [Related]
18. The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
J Oncol; 2021; 2021():3006853. PubMed ID: 34671398
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
Akbari P; Taebpour M; Akhlaghi M; Hasan SH; Shahriyari S; Parsaeian M; Haghirosadat BF; Rahdar A; Pandey S
Med Oncol; 2024 Jan; 41(3):68. PubMed ID: 38289404
[TBL] [Abstract][Full Text] [Related]
20. Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.
Sohn SI; Priya A; Balasubramaniam B; Muthuramalingam P; Sivasankar C; Selvaraj A; Valliammai A; Jothi R; Pandian S
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
